Jennison Associates LLC Purchases 13,945 Shares of Humana Inc. (NYSE:HUM)

Jennison Associates LLC increased its stake in shares of Humana Inc. (NYSE:HUM) by 4.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 333,725 shares of the insurance provider’s stock after buying an additional 13,945 shares during the quarter. Jennison Associates LLC owned 0.28% of Humana worth $105,704,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Humana in the third quarter valued at $1,778,000. Banque Cantonale Vaudoise lifted its holdings in Humana by 8.9% in the 3rd quarter. Banque Cantonale Vaudoise now owns 11,387 shares of the insurance provider’s stock worth $3,606,000 after buying an additional 927 shares during the period. Quest Partners LLC bought a new stake in Humana in the third quarter valued at $701,000. S&CO Inc. increased its position in Humana by 16.4% during the 3rd quarter. S&CO Inc. now owns 33,760 shares of the insurance provider’s stock valued at $10,693,000 after buying an additional 4,762 shares in the last quarter. Finally, Thrivent Financial for Lutherans raised its holdings in Humana by 55.6% in the third quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock worth $190,145,000 after buying an additional 214,535 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on HUM. Leerink Partners downgraded shares of Humana from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $400.00 to $250.00 in a report on Wednesday, October 2nd. TD Cowen increased their target price on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Leerink Partnrs cut Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Jefferies Financial Group downgraded shares of Humana from a “buy” rating to a “hold” rating and dropped their target price for the stock from $519.00 to $253.00 in a research note on Monday, October 7th. Finally, Stephens restated an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a report on Wednesday, October 9th. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Humana presently has an average rating of “Hold” and an average target price of $315.86.

Humana Trading Up 5.8 %

Shares of NYSE:HUM opened at $294.02 on Thursday. The stock has a market cap of $35.40 billion, a price-to-earnings ratio of 26.04, a PEG ratio of 2.17 and a beta of 0.52. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $527.18. The business has a 50-day moving average price of $277.86 and a 200-day moving average price of $331.03. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities analysts predict that Humana Inc. will post 15.86 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.20%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.